Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In the first clinical trial of its kind, US researchers found that people with late-life agitation and dementia who took a special medical formulation of two active ingredients found in marijuana – THC and CBD – had significantly less agitation than people who received a placebo. Source link
